Table 2.
Secondary outcomes: differences between immediate DAFNE and delayed DAFNE groups at six months. Values are means (SDs) unless stated otherwise
| Group
|
W-BQ12
|
Diabetes treatment satisfaction questionnaire (DTSQ)
|
Cardiovascular risk factors
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total wellbeing*
|
Total satisfaction*
|
Perceived frequency† of:
|
Weight (kg)
|
Total cholesterol (mmol/l)
|
HDL cholesterol (mmol/l)
|
Triglycerides (mmol/l)
|
||||
| Hyperglycaemia
|
Hypoglycaemia
|
|||||||||
| Immediate DAFNE: | ||||||||||
| Baseline | 20.94 (5.8) | 22.88 (6.2) | 3.57 (1.4) | 2.04 (1.2) | 80.5 (16.7) | 5.2 (0.9) | 1.5 (0.4) | 1.5 (0.9) | ||
| 6 months | 24.34 (5.7) | 31.58 (3.9) | 2.90 (1.4) | 2.16 (1.3) | 81.5 (16.9) | 5.1 (0.8) | 1.6 (0.4) | 1.4 (0.7) | ||
| Delayed DAFNE: | ||||||||||
| Baseline | 21.09 (5.8) | 23.21 (5.8) | 3.60 (1.6) | 2.12 (1.4) | 77.4 (13.4) | 4.9 (0.8) | 1.5 (0.5) | 1.5 (0.9) | ||
| 6 months | 21.37 (5.5) | 22.82 (6.0) | 4.03 (1.3) | 2.40 (1.3) | 77.3 (13.4) | 5.0 (1.0) | 1.5 (0.3) | 1.5 (0.9) | ||
| Difference between groups at six months | ||||||||||
| Mean (95% CI) | 2.98 (1.06 to 4.89) |
8.75 (7.02 to 10.48)‡ |
−1.13 (−1.59 to −0.67) |
−0.23 (−0.68 to 0.21) |
4.18 (−0.90 to 9.27) |
0.15 (−0.16 to 0.45) |
0.09 (−0.01 to 0.22) |
0.12 (−0.41 to 0.17) |
||
| Statistical values | t=3.1, P<0.01 | t=−10.3, P<0.0001 | t=−4.88, P<0.0001 | t=−1.0, P=0.31 | t=1.6, P=0.11 | t=0.95, P=0.34 | t=1.46, P=0.14 | t=0.83, P=0.41 | ||
HDL=high density lipoprotein; W-BQ12=12-item well-being questionnaire.
*
Scored from 0 to 36; a higher score indicates greater wellbeing or satisfaction.
†
Scored from 0 to 6; a higher score indicates greater perceived frequency of hyperglycaemia or hypoglycaemia.
‡
Confidence interval should be interpreted with caution as variable was transformed before parametric analysis was performed but natural data are reported.